KOD - CIK 0001468748
The table below shows Kodiak Sciences Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $48.55M | $50.48M | $42.76M | $43.64M | $31.88M | $32.51M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $11.23M |
| $11.88M |
| $12.75M |
| $15.43M |
| $14.75M |
| $15.47M |
| Operating income | -$59.78M | -$62.35M | -$55.51M | -$59.07M | -$46.63M | -$47.98M |
| Income tax | - | - | - | - | - | - |
| Net income | -$58.16M | -$61.46M | -$54.31M | -$57.46M | -$43.95M | -$45.12M |
| EPS (diluted) | -$0.94 | -$1.16 | -$1.03 | -$1.09 | -$0.84 | -$0.86 |